It has been known for some years that mother and baby exchange stem cells in the course of pregnancy, and that these may live on for many years, apparently tolerated by the new host. The phenomenon is known as microchimerism, and it is still unclear as to whether the presence of such cells can be harmful to the recipient. A Bristol team has looked for maternal cells in children with type 1 diabetes, an immune-mediated disorder, and found that around 20 per cent of these children have unusually high levels of maternal DNA in their circulation. An even more surprising finding is that some maternal cells have entered the child's pancreas and are functioning there as insulin-producing beta cells. The study, initially undertaken in the belief that maternal cells might trigger autoimmunity in the child, has now taken an interesting new twist, for the maternal cells might even be helping the child to repair injury.
In this study, published in the January 22 issue of the Proceedings of the National Academy of Sciences, Dr Kathleen Gillespie and Professor Edwin Gale from the Department of Clinicl Science @ North Bristol in collaboration with Professor J. Lee Nelson and colleagues at Fred Hutchinson Cancer Research Center, Seattle, found no evidence that the mother's cells were attacking the child's insulin cells and no evidence that the maternal cells were targets of an immune response from the child's immune system.
Instead, the researchers found a small number of female islet beta cells in male pancreatic tissue (procured from autopsies) that produced insulin. Microchimerism is the term used when an individual harbors cells or DNA that originate from another genetically distinct individual. "To our knowledge a maternal contribution to endocrine function has not previously been described," the authors said. "Our findings also raise the possibility that naturally acquired microchimerism might be exploited to therapeutic benefit."